Showing results (71-80 of 106) with videos related to
Sort By:
Pageof 11
Blood|April 2, 2014
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AMLJeffrey E Lancet, Jorge E Cortes, Donna E Hogge, et al.Leukemia|December 17, 2005
Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trialsN Dhédin, H Dombret, X Thomas, et al.Genome Biology|July 17, 2025
Direct genetic transformation bypasses tumor-associated DNA methylation alterationsSara Hetzel, Eran Hodis, Elena Torlai Triglia, et al.Annals of Hematology|April 30, 2022
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromesMikkael A Sekeres, Michael Schuster, Magalie Joris, et al.Blood Advances|February 23, 2018
Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemiaTibor J Kovacsovics, Alice Mims, Mohamed E Salama, et al.Leukemia|July 6, 2007
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trialE Tavernier, J-M Boiron, F Huguet, et al.Blood|February 21, 2004
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 scheduleMichele Ghielmini, Shu-Fang Hsu Schmitz, Sergio B Cogliatti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2004
Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trialXavier Thomas, Jean-Michel Boiron, Françoise Huguet, et al.Advances in Hematology|November 24, 2025
Treatment Patterns and Outcomes of Patients With Myelodysplastic Syndrome (MDS) by IPSS-R Scores at Academic Cancer CentersConnor Willis, Andre Hejazi, Vonetta L Williams, et al.Haematologica|May 25, 2010
Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup TrialTheo de Witte, Anne Hagemeijer, Stefan Suciu, et al.Pageof 11